Daratumumab in HLA Desensitization Prior to Transplantation
Clinical trial NCT05300451 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05300451
- Sponsor
- Barry A. Boilson
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2026-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.